Cargando…

Safety of Anthroposophic Medicinal Products: An Analysis of Adverse Drug Reactions from German Pharmacovigilance Databases

BACKGROUND: Anthroposophic medicinal products (AMPs) are widely used in Europe and world-wide. OBJECTIVE: To determine the frequency of reported adverse drug reactions (ADRs) from all AMPs on the market, in absolute numbers and relative to the maximum daily administration doses (MDADs). PATIENTS AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jong, Miek C., van Wietmarschen, Herman, Glockmann, Anja, Baars, Erik W., Hamre, Harald J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605942/ https://www.ncbi.nlm.nih.gov/pubmed/34322827 http://dx.doi.org/10.1007/s40801-021-00262-7

Ejemplares similares

Use and Safety of Anthroposophic Medicinal Products: An Analysis of 44,662 Patients from the EvaMed Pharmacovigilance Network
por: Hamre, Harald Johan, et al.
Publicado: (2017)

Use and Safety of Anthroposophic Medications for Acute Respiratory and Ear Infections: A Prospective Cohort Study
por: Hamre, Harald J., et al.
Publicado: (2007)

Antibiotic Use in Children with Acute Respiratory or Ear Infections: Prospective Observational Comparison of Anthroposophic and Conventional Treatment under Routine Primary Care Conditions
por: Hamre, Harald J., et al.
Publicado: (2014)

Anthroposophic Medicinal Products: A Literature Review of Features, Similarities and Differences to Conventional Medicinal Products, Scientific and Regulatory Assessment
por: Baars, Erik W., et al.
Publicado: (2022)

Anthroposophic Medicine: An Integrative Medical System Originating in Europe
por: Kienle, Gunver S., et al.
Publicado: (2013)

Anthroposophic therapy for chronic depression: a four-year prospective cohort study
por: Hamre, Harald J, et al.
Publicado: (2006)

Anthroposophic medical therapy in chronic disease: a four-year prospective cohort study
por: Hamre, Harald J, et al.
Publicado: (2007)

Health costs in anthroposophic therapy users: a two-year prospective cohort study
por: Hamre, Harald J, et al.
Publicado: (2006)

Outcome of anthroposophic medication therapy in chronic disease: A 12-month prospective cohort study
por: Hamre, Harald J, et al.
Publicado: (2009)

Overview of the Publications From the Anthroposophic Medicine Outcomes Study (AMOS): A Whole System Evaluation Study
por: Hamre, Harald Johan, et al.
Publicado: (2014)

Anthroposophic therapy for attention deficit hyperactivity: a two-year prospective study in outpatients
por: Hamre, Harald J, et al.
Publicado: (2010)

Anthroposophic Therapy for Migraine: A Two-Year Prospective Cohort Study in Routine Outpatient Settings
por: Hamre, Harald J, et al.
Publicado: (2010)

Anthroposophic therapy for asthma: A two-year prospective cohort study in routine outpatient settings
por: Hamre, Harald J, et al.
Publicado: (2009)

Anthroposophic therapy for children with chronic disease: a two-year prospective cohort study in routine outpatient settings
por: Hamre, Harald J, et al.
Publicado: (2009)

Long-term outcomes of anthroposophic therapy for chronic low back pain: A two-year follow-up analysis
por: Hamre, Harald J, et al.
Publicado: (2009)

Long-term outcomes of anthroposophic treatment for chronic disease: a four-year follow-up analysis of 1510 patients from a prospective observational study in routine outpatient settings
por: Hamre, Harald Johan, et al.
Publicado: (2013)

Predictors of outcome after 6 and 12 months following anthroposophic therapy for adult outpatients with chronic disease: a secondary analysis from a prospective observational study
por: Hamre, Harald J, et al.
Publicado: (2010)

Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings
por: Hamre, Harald J., et al.
Publicado: (2009)

The consumer quality index anthroposophic healthcare: a construction and validation study
por: Koster, Evi B, et al.
Publicado: (2014)

Fatal Events Associated with Adverse Drug Reactions in the Korean National Pharmacovigilance Database
por: Jo, Hyeong-Geun, et al.
Publicado: (2021)

Depression, Comorbidities, and Prescriptions of Antidepressants in a German Network of GPs and Specialists with Subspecialisation in Anthroposophic Medicine: A Longitudinal Observational Study
por: Jeschke, Elke, et al.
Publicado: (2012)

Combined bias suppression in single-arm therapy studies
por: Hamre, Harald J, et al.
Publicado: (2008)

Comparative analysis of resource utilization in integrative anthroposophic and all German pediatric inpatient departments
por: Fetz, Katharina, et al.
Publicado: (2020)

Fever: Views in Anthroposophic Medicine and Their Scientific Validity
por: Martin, David D.
Publicado: (2016)

Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

Adverse Drug Reactions and Potentially Inappropriate Medication in Older Patients: Analysis of the Portuguese Pharmacovigilance Database
por: Gomes, Daniel, et al.
Publicado: (2022)

Assessing the order of magnitude of outcomes in single-arm cohorts through systematic comparison with corresponding cohorts: An example from the AMOS study
por: Hamre, Harald J, et al.
Publicado: (2008)

Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions
por: Karapetiantz, Pierre, et al.
Publicado: (2018)

The oil-dispersion bath in anthroposophic medicine – an integrative review
por: Büssing, Arndt, et al.
Publicado: (2008)

Antibacterial in vitro effects of preparations from Anthroposophical Medicine
por: Roser, Eva, et al.
Publicado: (2016)

Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation
por: Ozcan, Gulnihal, et al.
Publicado: (2016)

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
por: Ruggiero, Rosanna, et al.
Publicado: (2020)

A Sex- and Gender-Based Analysis of Adverse Drug Reactions: A Scoping Review of Pharmacovigilance Databases
por: Brabete, Andreea C., et al.
Publicado: (2022)

Signal Detection of Adverse Drug Reactions of Cephalosporins Using Data from a National Pharmacovigilance Database
por: Choi, Jung-Yoon, et al.
Publicado: (2021)

Reports of Symptoms Associated with Supraventricular Arrhythmias as a Serious Adverse Drug Reaction in the Spanish Pharmacovigilance Database
por: Pueyo-Val, Javier, et al.
Publicado: (2023)

Effectiveness of herbal medicines to prevent and control symptoms of urinary tract infections and to reduce antibiotic use: A literature review
por: van Wietmarschen, Herman, et al.
Publicado: (2022)

Whole Medical Systems versus the System of Conventional Biomedicine: A Critical, Narrative Review of Similarities, Differences, and Factors That Promote the Integration Process
por: Baars, Erik W., et al.
Publicado: (2017)

Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
por: Allouchery, Marion, et al.
Publicado: (2021)

Adverse Drug Reactions with HER2-Positive Breast Cancer Treatment: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2021)

Adverse drug reactions associated with ivermectin use for COVID-19 reported in the World Health Organization's pharmacovigilance database
por: Campillo, Jeremy T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vihkragjev6fc0uedsefperhqp